Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Research And Development Services — Revenue

Similar metrics at other companies

Arcus Biosciences logo
RCUSR&D services — Total revenues
$2M0.0%
Nuvation Bio logo
NUVBResearch And Development Service Revenue — Revenue
$700K-63.2%
Ionis Pharmaceuticals logo
IONSResearch And Development Revenue — Revenue
$138.28M+149%
IQVIA logo
IQVResearch & Development Solutions — Revenue
$2.4B+6.2%
Hyliion logo
HYLNResearch and development services — Cost of revenues
$2.62M+450%
BioCryst Pharmaceuticals logo
BCRXResearch and Development — Contract with customer, transaction price
$20.67M—

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.4%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's research and development services — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's research and development services — revenue?
Amphastar Pharmaceuticals (AMPH) reported research and development services — revenue of $2.5M in Q1 2026.
How has Amphastar Pharmaceuticals's research and development services — revenue changed year-over-year?
Amphastar Pharmaceuticals's research and development services — revenue increased by 2400.0% year-over-year, from $100K to $2.5M.
What is the long-term trend for Amphastar Pharmaceuticals's research and development services — revenue?
Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's research and development services — revenue has grown at a -11.0% compound annual growth rate (CAGR), from $5.1M to $3.2M.
What does research and development services — revenue mean?
This metric represents the total revenue generated from providing specialized research and development services to third-party clients. It reflects the company's ability to monetize its technical expertise and laboratory infrastructure beyond its internal product development pipeline. Monitoring this revenue stream helps investors assess the stability and growth potential of the company's contract research or collaborative service offerings.